Ex Vivo Immune Responsiveness to SARS-CoV-2 Omicron BA.5.1 Following Vaccination with Unmodified mRNA-Vaccine

Ex Vivo Immune Responsiveness to SARS-CoV-2 Omicron BA.5.1 Following Vaccination with Unmodified mRNA-Vaccine

(1) Background: The high incidence of SARS-CoV-2 infection in vaccinated persons underscores the importance of individualized re-vaccination. PanIg antibodies that act against the S1/-receptor binding domain quantified in serum by a routine diagnostic test (ECLIA, Roche) can be used to gauge the ind...

Full description

Bibliographic Details
Main Authors: Anna Sabrina Kuechler, Eva Heger, Maike Wirtz, Sandra Weinhold, Markus Uhrberg, Fritz Boege, Karin Schulze-Bosse
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Vaccines
Subjects:
COVID 19-serology
SARS-CoV-2-neutralization
SARS-CoV-2-vaccination
SARS-CoV-2-immunity
companion-diagnostic
SARS-CoV-2 BA.5.1
Online Access:https://www.mdpi.com/2076-393X/11/3/598

Internet

https://www.mdpi.com/2076-393X/11/3/598

Similar Items